Newark, NJ, Feb. 11, 2021 (GLOBE NEWSWIRE) — As per the report published by Fior Markets, the global drug delivery technology market is expected to grow from USD 4827.03 billion in 2020 and to reach USD 9000.89 billion by 2028, growing at a CAGR of 8.1% during the forecast period 2021-2028.
The global drug delivery technology market is witnessing significant growth in recent years. This growth is attributed to the growing incidences of chronic diseases like diabetes, cancer, technological advancements, and a rising focus on geriatric and pediatric patients. Other factors like increasing demand for invasive surgeries and lifestyle changes propel the market for drug delivery technology.
Drug delivery is a procedure or technique that is used to deliver drugs to a targeted site with the aim of a curative solution. The drug delivery technology enhances the drug release profile, absorption, distribution, and elimination to develop product safety and efficiency with the patient’s ease and comfort. The drug delivery technology helps in controlling the time and rate of the drug released in the body. The drug delivery process plays an important role in driving the efficacy and safety of the drug.
The global drug delivery technology market is expected to witness significant growth, owing to the emergence of advanced technologies, increased research and development activities, and increasing demand for drug delivery technology that can be self-administered. The factors restraining the market growth are the rising prevalence of needlestick injuries, side effects associated with drugs, and the high cost of the treatment. The growing biopharmaceutical market and increasing demand for drug delivery technology provide market growth opportunities.
DOWNLOAD FREE SAMPLE REPORT AT https://www.fiormarkets.com/report-detail/419205/request-sample
The key players operating in the global drug delivery technology include F. Hoffmann-La Roche Ltd, Antares Pharma, Inc., Johnson & Johnson Services, Inc., Pfizer Inc., West Pharmaceutical Services Inc., Merck & Co., Inc., GlaxoSmithKline plc, Novartis AG, 3M, Sanofi, and Bayer AG. To gain a significant market share in the global drug delivery technology market, the key players are now focusing on adopting strategies such as product innovations, mergers & acquisitions, recent developments, joint ventures, collaborations, and partnerships.
- For instance, in October 2020, NovaPure 3mL Cartridge components and the SmartDose Gen. was launched by West Pharmaceutical Services. This launch will help the company to enhance its product portfolio in the market.
Oral Route segment dominated the market and held the largest market share of 29.4% in the year 2020
On the basis of route of administration, the global drug delivery technology market is segmented into a parenteral route, oral route, inhalation route, transdermal route, and nasal drug delivery. Oral Route segment dominated the market and held the largest market share of 29.4% in the year 2020. This growth is attributed to the ease of storage, cost-effectiveness, easy portability, and non-invasive nature of the oral route.
Hospitals segment dominated the market and held the largest share of 33.6% in the year 2020
On the basis of end-user, the global drug delivery technology market is segmented into clinics, hospitals, home care settings, diagnostic centers, and others. Hospitals segment dominated the market and held the largest share of 33.6% in the year 2020. This growth is attributed to the increasing preferences for hospitals by the large patient pool.
Browse full report with TOC at https://www.fiormarkets.com/report/drug-delivery-technology-market-by-route-of-administration-419205.html
Regional Segment of Drug Delivery Technology Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and Rest of South America)
- Middle East and Africa (UAE, South Africa, Rest of MEA)
On the basis of geography, the global drug delivery technology market is classified into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America held the major share of 37.52% in the year 2020. This growth is attributed to the adoption of novel non-drug administration modes like implantable, pulmonary, and transdermal drug delivery, the government supports, and rising focus in R&D. The Asia-Pacific region is anticipated to witness significant growth, owing to rising investments by major players, large patient pools, low labor costs, an increasing number of clinical trials.
Request for Customization: https://www.fiormarkets.com/enquiry/request-customization/419205
About the report:
The global drug delivery technology market is analysed on the basis of value (USD billion). All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insights of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitors position grid analysis.
For Instant Purchase: https://www.fiormarkets.com/checkout.html?reportid=419205&type=single
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on firstname.lastname@example.org or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
About Fior Markets
Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients’ objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. Fior Markets deploys a wide range of regional and global market intelligence research reports including industries like technology, pharmaceutical, consumer goods, food and beverages, chemicals, media, materials and many others. Our Strategic Intelligence capabilities are purposely planned to boost your business extension and elucidate the vigor of diverse industry. We hold distinguished units of highly expert analysts and consultants according to their respective domains. The global market research reports we provide involve both qualitative and quantitative analysis of current market scenario as per the geographical regions segregated and comprehensive performance in different regions with global approach. In addition, our syndicated research reports offer a packaged guide to keep companies abreast of the upcoming major restyle in their domains. Fior Markets facilitates clients with research analysis that are customized to their exact requirements, specifications and challenges, whether it is comprehensive desk research, survey work, composition of multiple methods, in-detailed interviewing or competitive intelligence. Our research experts are experienced in matching the exact personnel and methodology to your business need.
Head of Business Development
To Read Top Industries Reports, Visit our Affiliated Website: https://www.marketsandresearch.biz
Cord Blood Banking Market – https://www.fiormarkets.com/report/cord-blood-banking-market-by-type-of-bank-418891.html
Cosmetic Implants Market – https://www.fiormarkets.com/report/cosmetic-implants-market-by-raw-material-polymer-implants-418892.html
Atrial Fibrillation Surgery Market – https://www.fiormarkets.com/report/atrial-fibrillation-surgery-market-by-surgical-procedure-catheter-418888.html
Inhalation Anesthesia Market – https://www.fiormarkets.com/report/inhalation-anesthesia-market-by-product-sevoflurane-isoflurane-desflurane-418903.html